IN2014MN01871A - - Google Patents

Info

Publication number
IN2014MN01871A
IN2014MN01871A IN1871MUN2014A IN2014MN01871A IN 2014MN01871 A IN2014MN01871 A IN 2014MN01871A IN 1871MUN2014 A IN1871MUN2014 A IN 1871MUN2014A IN 2014MN01871 A IN2014MN01871 A IN 2014MN01871A
Authority
IN
India
Prior art keywords
riboflavin
hydrates
group
relates
present
Prior art date
Application number
Other languages
English (en)
Inventor
Ciro Caruso
Salvatore Troisi
Original Assignee
Iros R C S R L
Del Prete Antonio
Sanseverino Renato
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iros R C S R L, Del Prete Antonio, Sanseverino Renato filed Critical Iros R C S R L
Publication of IN2014MN01871A publication Critical patent/IN2014MN01871A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/16Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring intraocular pressure, e.g. tonometers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/006Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Surgery (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Oncology (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1871MUN2014 2012-03-07 2013-03-01 IN2014MN01871A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000355A ITMI20120355A1 (it) 2012-03-07 2012-03-07 Sostanza colorante per uso diagnostico oftalmologico
PCT/IB2013/051635 WO2013132396A1 (en) 2012-03-07 2013-03-01 Coloring substance for diagnostic ophtalmologic use

Publications (1)

Publication Number Publication Date
IN2014MN01871A true IN2014MN01871A (zh) 2015-07-03

Family

ID=45999982

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1871MUN2014 IN2014MN01871A (zh) 2012-03-07 2013-03-01

Country Status (10)

Country Link
US (1) US9370587B2 (zh)
EP (1) EP2822604B1 (zh)
AU (1) AU2013229096B2 (zh)
BR (1) BR112014022177A2 (zh)
CA (1) CA2900792A1 (zh)
IN (1) IN2014MN01871A (zh)
IT (1) ITMI20120355A1 (zh)
RU (1) RU2639915C2 (zh)
WO (1) WO2013132396A1 (zh)
ZA (1) ZA201407224B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000017059A1 (it) * 2020-07-14 2022-01-14 Frastema Ophthalmics Easyopht Group Srl In Forma Abbreviata Fe Group Srl Testa di applanazione monouso per tonometro ad applanazione
WO2023172587A1 (en) * 2022-03-07 2023-09-14 Opus Life Sciences Llc Fluorescein formulations and kits

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2603632A (en) * 1949-04-06 1952-07-15 American Cyanamid Co Method of preparation of phosphoric acid esters of riboflavin
US5540227A (en) * 1995-05-17 1996-07-30 Poole; Thomas A. Controlled application of select ophthalmic agents
DE602005013423D1 (de) * 2004-12-06 2009-04-30 Univ Kyushu Nat Univ Corp Farbzusammensetzung zum einfärben einer ophthalmischen membran
US20090192437A1 (en) * 2007-09-24 2009-07-30 The Johns Hopkins University Wearable photoactivator for ocular therapeutic applications and uses thereof
JP2013500302A (ja) * 2009-07-27 2013-01-07 サンセベリノ,レナト Uv−a線に対する眼球内部構造保護用又は経上皮架橋術式による円錐角膜の治療用点眼液
DE102009056597A1 (de) * 2009-12-02 2011-06-09 Tobias Brockmann Verwendung von Flavin-Derivaten zur Behandlung von Pathologien an der Membrana limitans interna (ILM)
EP2392355A1 (en) * 2010-06-03 2011-12-07 Medical Technology Transfer Holding B.V. Staining composition

Also Published As

Publication number Publication date
US20140371569A1 (en) 2014-12-18
ITMI20120355A1 (it) 2013-09-08
EP2822604B1 (en) 2018-09-05
AU2013229096B2 (en) 2017-03-23
RU2639915C2 (ru) 2017-12-25
AU2013229096A1 (en) 2014-10-23
BR112014022177A2 (pt) 2017-11-14
EP2822604A1 (en) 2015-01-14
ZA201407224B (en) 2016-05-25
RU2014139766A (ru) 2016-04-27
US9370587B2 (en) 2016-06-21
CA2900792A1 (en) 2013-09-12
WO2013132396A1 (en) 2013-09-12

Similar Documents

Publication Publication Date Title
HRP20151103T1 (en) Substituted triazolopyridines and their use as ttk inhibitors
GB2503411B (en) Sorting apparatus for arthropods and method of use thereof
SG11201504022RA (en) Glutamase inhibitors and method of use
IL236678B (en) Crystallin-alpha inhibitors for the treatment of cataracts
EP2901409A4 (en) SYSTEMS AND METHOD FOR PRODUCING INVENTORIES FOR USE ON THE ROAD
PL2874660T3 (pl) Preparat okulistyczny i sposób łagodzenia starczowzroczności
EP3038646A4 (en) Diagnostic methods and compositions for treatment of glioblastoma
HK1216146A1 (zh) 眼藥組合物、其製備方法及用途
IN2015DN01902A (zh)
HK1222562A1 (zh) 用於醫學診斷的組合物及方法
EP3068758A4 (en) Ebna1 inhibitors and their method of use
EP3003290A4 (en) Compositions and methods for induced tissue regeneration in mammalian species
EP2991627A4 (en) BLOOD SUCCANTED COMPOSITION AND METHOD OF USE
EP2895068A4 (en) SYSTEM AND METHOD FOR MEASURING THE HEART TIME VOLUME
EP2820615A4 (en) SYSTEM AND METHOD FOR THE PRODUCTION OF MEDICAL REPORTS
EP3038663A4 (en) Method of performing sterilization cycle
EP2915513A4 (en) ABSORBENT FOR ABSORBENT ARTICLE AND METHOD FOR PRODUCING SAME
SI2541503T1 (sl) Postopek in sistem za merjenje obrobja RF-ZVEZE
HK1201602A1 (zh) 種生成消息索引以便向接收者呈現消息的方法及裝置
GB2517113B (en) Method involving pre-treating medical instruments
IL239117A0 (en) A method for metachromatic leukodystrophy diagnosis
IN2014MN01871A (zh)
HK1223555A1 (zh) 用於減少眼內壓的組合物和方法
SG11201500503TA (en) Apparatus for measuring the topography and thickness of the cornea and measuring method used
IL238934A0 (en) Methods for the preparation of phenyloxymethyl-nitro-imidazole derivatives and their use